4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0000947871-24-000703
Director sold 250,000 shares at $44.01 ($11,002,500)
From the SEC's structured data for this filing
Trades in this filing
GORDON CARL L · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-13 | Sale : show line 1 in the form | −220,600 | $44.01 | $9,708,606 | 899,212 | I |
| 2024-08-13 | Sale : show line 2 in the form | −29,400 | $44.01 | $1,293,894 | 119,522 | I |
| Open-market sales · 250,000 sh · avg $44.01 · $11,002,500 | ||||||
Loading xslF345X05/ownership.xml…